메뉴 건너뛰기




Volumn 22, Issue 9, 2007, Pages 2429-2431

A primer on iron therapy

Author keywords

Anaphylactoid reactions; Chronic kidney disease; Erythropoiesis stimulating agents (ESA); intravenous iron therapy; Renal anaemia

Indexed keywords

ASCORBIC ACID; COSMOFER; ERYTHROPOIETIN; FERRIC GLUCONATE; FERRIC HYDROXIDE SUCROSE; FERRITIN; HEMOGLOBIN; IRON; IRON DEXTRAN; TRANSFERRIN; UNCLASSIFIED DRUG;

EID: 34548403940     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm287     Document Type: Note
Times cited : (9)

References (20)
  • 1
    • 33846694048 scopus 로고    scopus 로고
    • Clinical aspects of iron use in the anemia of kidney disease
    • Hörl WH. Clinical aspects of iron use in the anemia of kidney disease. J Am Soc Nephrol 2007; 18: 382-393
    • (2007) J Am Soc Nephrol , vol.18 , pp. 382-393
    • Hörl, W.H.1
  • 2
    • 33750073824 scopus 로고    scopus 로고
    • Investigating iron status in microcytic. anaemia
    • Galloway MJ, Smellie WS. Investigating iron status in microcytic. anaemia. Br Med J 2006; 333: 791-793
    • (2006) Br Med J , vol.333 , pp. 791-793
    • Galloway, M.J.1    Smellie, W.S.2
  • 4
    • 33646345152 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. Am J Kidney Dis 2006; 47 [Suppl. 3, S11-S145
    • K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. Am J Kidney Dis 2006; 47 [Suppl. 3]: S11-S145
  • 5
    • 0038100425 scopus 로고    scopus 로고
    • Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients
    • Keven K, Kutlay S, Nergizogly G, Ertürk S. Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients. Am J Kidney Dis 2003; 41: 1233-1239
    • (2003) Am J Kidney Dis , vol.41 , pp. 1233-1239
    • Keven, K.1    Kutlay, S.2    Nergizogly, G.3    Ertürk, S.4
  • 6
    • 0032942458 scopus 로고    scopus 로고
    • Hypochromic red blood cells and reticulocytes
    • Schaefer RM, Schaefer L. Hypochromic red blood cells and reticulocytes. Kidney Int 1999; 55 [Suppl. 69]: S44-S48
    • (1999) Kidney Int , vol.55 , Issue.SUPPL. 69
    • Schaefer, R.M.1    Schaefer, L.2
  • 7
    • 0035176486 scopus 로고    scopus 로고
    • A randomized trial of iron deficiency testing strategies in hemodialysis patients
    • Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J. A randomized trial of iron deficiency testing strategies in hemodialysis patients. Kidney Int 2001; 60: 2406-2411
    • (2001) Kidney Int , vol.60 , pp. 2406-2411
    • Fishbane, S.1    Shapiro, W.2    Dutka, P.3    Valenzuela, O.F.4    Faubert, J.5
  • 8
    • 33748997056 scopus 로고    scopus 로고
    • Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states
    • Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haematol 2006; 28: 303-308
    • (2006) Clin Lab Haematol , vol.28 , pp. 303-308
    • Brugnara, C.1    Schiller, B.2    Moran, J.3
  • 9
    • 0344699450 scopus 로고    scopus 로고
    • Hypochromic red cells and reticulocyte haemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis
    • Cullen P, Söffker J, Höpfl M et al. Hypochromic red cells and reticulocyte haemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis. Nephrol Dial Transplant 1999; 14: 659-665
    • (1999) Nephrol Dial Transplant , vol.14 , pp. 659-665
    • Cullen, P.1    Söffker, J.2    Höpfl, M.3
  • 10
    • 34548417623 scopus 로고    scopus 로고
    • Product information CosmoFer®. GRY-Pharma, 2001.
    • Product information CosmoFer®. GRY-Pharma, 2001.
  • 11
    • 34548412658 scopus 로고    scopus 로고
    • Product information Ferrlecit®. Aventis Pharma, 2001.
    • Product information Ferrlecit®. Aventis Pharma, 2001.
  • 12
    • 34548429238 scopus 로고    scopus 로고
    • Product information Venofer®. Fresenius Medical Care, 1999.
    • Product information Venofer®. Fresenius Medical Care, 1999.
  • 14
    • 26044476338 scopus 로고    scopus 로고
    • Hypersensitivity reactions and deaths associated with intravenous iron preparations
    • Bailie GR, Clark JA, Lane CE, Lane PL. Hypersensitivity reactions and deaths associated with intravenous iron preparations. Nephrol Dial Transplant 2005; 20: 1443-1449
    • (2005) Nephrol Dial Transplant , vol.20 , pp. 1443-1449
    • Bailie, G.R.1    Clark, J.A.2    Lane, C.E.3    Lane, P.L.4
  • 15
    • 0345099328 scopus 로고    scopus 로고
    • Intravenous iron as adjuvant therapy: A two-edged sword?
    • Viii24-viii28
    • Cavill I. Intravenous iron as adjuvant therapy: A two-edged sword? Nephrol Dial Transplant 2003; 18: Viii24-viii28
    • (2003) Nephrol Dial Transplant , pp. 18
    • Cavill, I.1
  • 16
    • 4344581912 scopus 로고    scopus 로고
    • Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 2004; 19 [Suppl. 2, Ii1-ii47
    • Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 2004; 19 [Suppl. 2]: Ii1-ii47
  • 17
    • 0034965685 scopus 로고    scopus 로고
    • A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo
    • Kosch M, Bahner U, Bettger H, Matzkies F, Teschner M, Schaefer RM. A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo. Nephrol Dial Transplant 2001; 16: 1239-1244
    • (2001) Nephrol Dial Transplant , vol.16 , pp. 1239-1244
    • Kosch, M.1    Bahner, U.2    Bettger, H.3    Matzkies, F.4    Teschner, M.5    Schaefer, R.M.6
  • 18
    • 4344560350 scopus 로고    scopus 로고
    • Iron sucrose in hemodialysis patients: Safety of replacement and maintenance regimens
    • Aronoff GR, Bennett WM, Blumenthal S et al. Iron sucrose in hemodialysis patients: Safety of replacement and maintenance regimens. Kidney Int 2004; 66: 1193-1198
    • (2004) Kidney Int , vol.66 , pp. 1193-1198
    • Aronoff, G.R.1    Bennett, W.M.2    Blumenthal, S.3
  • 19
    • 32844465284 scopus 로고    scopus 로고
    • A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD
    • Van Wyck DB, Roppolo M, Martinez CA et al. A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. Kidney Int 2005; 68: 2846-2856
    • (2005) Kidney Int , vol.68 , pp. 2846-2856
    • Van Wyck, D.B.1    Roppolo, M.2    Martinez, C.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.